Christian Brooks1, Valerie Gausman2, Chanthel Kokoy-Mondragon1, Khushboo Munot3, Sunil P Amin1, Amit Desai1, Claudine Kipp1, John Poneros1, Amrita Sethi1, Frank G Gress1, Michel Kahaleh4, Vundavalli V Murty5, Reem Sharaiha4, Tamas A Gonda6. 1. Division of Digestive and Liver Diseases, Columbia University Medical Center-NYP, New York, NY, USA. 2. Department of Medicine, NYU Langone Medical Center, New York, NY, USA. 3. Section of Gastroenterology and Hepatology, Baylor College of Medicine Medical Center, Houston, TX, USA. 4. Division of Gastroenterology and Hepatology, Weill Cornell Medical Center-NYP, New York, NY, USA. 5. Department of Pathology, Columbia University Medical Center-NYP, New York, NY, USA. 6. Division of Digestive and Liver Diseases, Columbia University Medical Center-NYP, New York, NY, USA. tg2214@cumc.columbia.edu.
Abstract
BACKGROUND AND AIMS: Our goal was to compare the diagnostic accuracy of FISH in the detection of malignancy compared with other standard diagnostic modalities, including brush cytology and biopsy specimens over a 10-year period of prospective data collection. METHODS: We conducted a review of all consecutive biliary strictures evaluated between 2006 and 2016. Patients with a final pathologic diagnosis or conclusive follow-up were included. We evaluated the performance of FISH polysomy (CEP 3, 7, and 17) and 9p21 deletion as well as cholangioscopic biopsy (CBx) and EUS-FNA. Statistical analysis was performed with the Mann-Whitney U and Fisher's exact tests. RESULTS: Of 382 patients with indeterminate strictures, 281 met inclusion criteria. Forty-nine percent were malignant. Cytology, FISH polysomy, and FISH polysomy/9p21 showed a specificity of 99.3%. FISH polysomy/9p21 as a single modality was the most sensitive at 56% (p < 0.001). The sensitivity of FISH polysomy/9p21 and cytology was significantly higher than cytology alone at 63 versus 35% (p < 0.05). EUS-FNA for distal strictures and CBx for proximal strictures increased sensitivity from 33 to 93% (p < 0.001) and 48-76% (p = 0.05) in cytology-negative strictures. CONCLUSIONS: The high specificity of FISH polysomy/9p21 suggests that a positive result is sufficient for diagnosing malignancy in indeterminate strictures. The significantly higher sensitivity of FISH polysomy/9p21 compared to cytology supports the use of FISH in all non-diagnostic cases. Although both EUS-FNA and CBx were complimentary, our results suggest that distal strictures should be evaluated by EUS initially. Proximal strictures may be evaluated by FISH first and then by CBx if inconclusive.
BACKGROUND AND AIMS: Our goal was to compare the diagnostic accuracy of FISH in the detection of malignancy compared with other standard diagnostic modalities, including brush cytology and biopsy specimens over a 10-year period of prospective data collection. METHODS: We conducted a review of all consecutive biliary strictures evaluated between 2006 and 2016. Patients with a final pathologic diagnosis or conclusive follow-up were included. We evaluated the performance of FISH polysomy (CEP 3, 7, and 17) and 9p21 deletion as well as cholangioscopic biopsy (CBx) and EUS-FNA. Statistical analysis was performed with the Mann-Whitney U and Fisher's exact tests. RESULTS: Of 382 patients with indeterminate strictures, 281 met inclusion criteria. Forty-nine percent were malignant. Cytology, FISH polysomy, and FISH polysomy/9p21 showed a specificity of 99.3%. FISH polysomy/9p21 as a single modality was the most sensitive at 56% (p < 0.001). The sensitivity of FISH polysomy/9p21 and cytology was significantly higher than cytology alone at 63 versus 35% (p < 0.05). EUS-FNA for distal strictures and CBx for proximal strictures increased sensitivity from 33 to 93% (p < 0.001) and 48-76% (p = 0.05) in cytology-negative strictures. CONCLUSIONS: The high specificity of FISH polysomy/9p21 suggests that a positive result is sufficient for diagnosing malignancy in indeterminate strictures. The significantly higher sensitivity of FISH polysomy/9p21 compared to cytology supports the use of FISH in all non-diagnostic cases. Although both EUS-FNA and CBx were complimentary, our results suggest that distal strictures should be evaluated by EUS initially. Proximal strictures may be evaluated by FISH first and then by CBx if inconclusive.
Entities:
Keywords:
Biliary strictures; Cholangiocarcinoma; ERCP; EUS-FNA; Fluorescence in situ hybridization; Pancreatic cancer
Authors: Benjamin R Kipp; Linda M Stadheim; Shari A Halling; Nicole L Pochron; Scott Harmsen; David M Nagorney; Thomas J Sebo; Terry M Therneau; Gregory J Gores; Piet C de Groen; Todd H Baron; Michael J Levy; Kevin C Halling; Lewis R Roberts Journal: Am J Gastroenterol Date: 2004-09 Impact factor: 10.864
Authors: Laura E Moreno Luna; Benjamin Kipp; Kevin C Halling; Thomas J Sebo; Walter K Kremers; Lewis R Roberts; Emily G Barr Fritcher; Michael J Levy; Gregory J Gores Journal: Gastroenterology Date: 2006-08-16 Impact factor: 22.682
Authors: Marcela Salomao; Tamas A Gonda; Elizabeth Margolskee; Vasco Eguia; Helen Remotti; John M Poneros; Amrita Sethi; Anjali Saqi Journal: Cancer Cytopathol Date: 2015-01-06 Impact factor: 5.284
Authors: Tamas A Gonda; Michael P Glick; Amrita Sethi; John M Poneros; Walter Palmas; Shahzad Iqbal; Susana Gonzalez; Subhadra V Nandula; Jean C Emond; Robert S Brown; Vundavalli V Murty; Peter D Stevens Journal: Gastrointest Endosc Date: 2011-11-17 Impact factor: 9.427
Authors: Emily G Barr Fritcher; Jesse S Voss; Sarah M Jenkins; Ravi K Lingineni; Amy C Clayton; Lewis R Roberts; Kevin C Halling; Jayant A Talwalkar; Gregory J Gores; Benjamin R Kipp Journal: Cancer Cytopathol Date: 2013-07-09 Impact factor: 5.284
Authors: Roongruedee Chaiteerakij; Emily G Barr Fritcher; Phonthep Angsuwatcharakon; Wiriyaporn Ridtitid; Supakarn Chaithongrat; Apinya Leerapun; Todd H Baron; Benjamin R Kipp; Michael R Henry; Kevin C Halling; Rungsun Rerknimitr; Lewis R Roberts Journal: Gastrointest Endosc Date: 2015-12-10 Impact factor: 9.427
Authors: Emily G Barr Fritcher; Benjamin R Kipp; Jesse S Voss; Amy C Clayton; Keith D Lindor; Kevin C Halling; Gregory J Gores Journal: Am J Gastroenterol Date: 2011-08-16 Impact factor: 10.864
Authors: Emily G Barr Fritcher; Benjamin R Kipp; Kevin C Halling; Trynda N Oberg; Sandra C Bryant; Robert F Tarrell; Gregory J Gores; Michael J Levy; Amy C Clayton; Thomas J Sebo; Lewis R Roberts Journal: Gastroenterology Date: 2009-02-14 Impact factor: 22.682
Authors: Emily G Barr Fritcher; Jesse S Voss; Shannon M Brankley; Michael B Campion; Sarah M Jenkins; Matthew E Keeney; Michael R Henry; Sarah M Kerr; Roongruedee Chaiteerakij; Ekaterina V Pestova; Amy C Clayton; Jun Zhang; Lewis R Roberts; Gregory J Gores; Kevin C Halling; Benjamin R Kipp Journal: Gastroenterology Date: 2015-08-29 Impact factor: 22.682
Authors: Emily G Barr Fritcher; Benjamin R Kipp; Jeffrey M Slezak; Laura E Moreno-Luna; Gregory J Gores; Michael J Levy; Lewis R Roberts; Kevin C Halling; Thomas J Sebo Journal: Am J Clin Pathol Date: 2007-08 Impact factor: 2.493
Authors: José María Huguet; Miriam Lobo; José Mir Labrador; Carlos Boix; Cecilia Albert; Luis Ferrer-Barceló; Ana B Durá; Patricia Suárez; Isabel Iranzo; Mireia Gil-Raga; Celia Baez de Burgos; Javier Sempere Journal: World J Clin Cases Date: 2019-07-26 Impact factor: 1.337